AIRE+ prostate cancer cells were shown to secrete increased levels of IL-6 and prostaglandin 2 (PGE2), which polarized the tumor-associated macrophage toward the M2 phenotype with an increased expression of CD206 and CD163 antigens. Here, IL6 is linked to neoplasm.